DESCRIPTION

In this response, the authors argue that cholesterol management in adults older than 75 years should be guided by individualized clinical judgment rather than age alone. Although high cholesterol continues to contribute to cardiovascular risk in older adults, the benefits and risks of treatment vary widely depending on factors such as overall health, frailty, life expectancy, other medical conditions, and patient goals. The letter emphasizes shared decision-making between clinicians and patients and highlights the need for more research to better inform treatment decisions in this growing population.